- Filed
- Jul 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jul 15, 2025 | 11.76M sh |
| Operating Cash Flow | Q1 2026 · May 31, 2025 | −$759.24K |
| Operating Cash Flow | Q1 2026 · May 31, 2024 | $246.18K |
| Cash And Equivalents | Q1 2026 · May 31, 2025 | $1.95M |
| Cash And Equivalents | Q1 2026 · Feb 28, 2025 | $2.77M |
| Cash And Equivalents | Q1 2026 · May 31, 2024 | $2.52M |
| Cash And Equivalents | Q1 2026 · Feb 29, 2024 | $2.81M |
| Stockholders Equity | Q1 2026 · May 31, 2025 | $4.37M |
| Stockholders Equity | Q1 2026 · Feb 28, 2025 | $4.27M |
| Stockholders Equity | Q1 2026 · May 31, 2024 | $2.25M |
| Stockholders Equity | Q1 2026 · Feb 29, 2024 | $2.17M |
| Current Liabilities | Q1 2026 · May 31, 2025 | $2.09M |
| Current Liabilities | Q1 2026 · Feb 28, 2025 | $1.51M |
| Total Liabilities | Q1 2026 · May 31, 2025 | $3.04M |
| Total Liabilities | Q1 2026 · Feb 28, 2025 | $2.54M |
| Current Assets | Q1 2026 · May 31, 2025 | $6.96M |
| Current Assets | Q1 2026 · Feb 28, 2025 | $6.42M |
| Total Assets | Q1 2026 · May 31, 2025 | $7.4M |
| Total Assets | Q1 2026 · Feb 28, 2025 | $6.81M |
| Eps Diluted | Q1 2026 · May 31, 2025 | $0.01 |
| Eps Diluted | Q1 2026 · May 31, 2024 | $0.01 |
| Eps Basic | Q1 2026 · May 31, 2025 | $0.01 |
| Eps Basic | Q1 2026 · May 31, 2024 | $0.01 |
| Sga Expense | Q1 2026 · May 31, 2025 | −$569.58K |
| Sga Expense restated | Q1 2026 · May 31, 2024 | −$277.21K |
| Rd Expense | Q1 2026 · May 31, 2025 | −$49.01K |
| Rd Expense | Q1 2026 · May 31, 2024 | −$14.98K |
| Net Income | Q1 2026 · May 31, 2025 | $113.78K |
| Net Income | Q1 2026 · May 31, 2024 | $87.2K |
| Operating Income | Q1 2026 · May 31, 2025 | $277.46K |
| Operating Income | Q1 2026 · May 31, 2024 | $269.17K |
| Gross Profit | Q1 2026 · May 31, 2025 | $925.33K |
| Gross Profit restated | Q1 2026 · May 31, 2024 | $600.28K |
| Cost Of Revenue | Q1 2026 · May 31, 2025 | −$1.21M |
| Cost Of Revenue restated | Q1 2026 · May 31, 2024 | −$651.6K |
| Revenue | Q1 2026 · May 31, 2025 | $2.13M |
| Revenue restated | Q1 2026 · May 31, 2024 | $1.25M |
| Capex | Q1 2026 · May 31, 2024 | −$6.06K |